Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial
Clinical trial NCT05508464 · RECRUITING
Trial details
- NCT number
- NCT05508464
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2034-01-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.